Warning letter
Pharmaceutical Laboratories and Consultants, Inc.: warning letter of Jul 25, 2007
FDA warning letter UCM076452 · Chicago District Office
Key facts
| Reference number | UCM076452 |
|---|---|
| Company | Pharmaceutical Laboratories and Consultants, Inc. |
| Subject | Current Good Manufacturing Practice/Adulterated |
| Issue date | Jul 25, 2007 |
| Posted date | Jul 25, 2007 |
| Issuing office | Chicago District Office |
| Product type | Unknown |
| CFR sections cited | 211.160(b), 211.194(a)(4), 211.165(e) |
| Country | 3 |
| Inspection city | Addison |
| Inspection ZIP | 60101-4333 |
| Inspection start date | Apr 16, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: